Blarcamesine is a Sigma-1 receptor agonist and muscarinic receptor modulator with anticonvulsant, anti-amnesic, neuroprotective, and antidepressant properties; it improves neurological impairments in a mouse model of Rett syndrome; ameliorates motor deficits, acoustic startle deficits, and visual acuity deficits in Mecp2 heterozygous (HET) mice; and shows minimal effects on body weight gain in these animals.